Hua Lin

2.1k total citations · 1 hit paper
40 papers, 1.5k citations indexed

About

Hua Lin is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Control and Systems Engineering. According to data from OpenAlex, Hua Lin has authored 40 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 12 papers in Molecular Biology and 10 papers in Control and Systems Engineering. Recurrent topics in Hua Lin's work include Smart Grid Security and Resilience (9 papers), Lung Cancer Treatments and Mutations (5 papers) and Metabolomics and Mass Spectrometry Studies (4 papers). Hua Lin is often cited by papers focused on Smart Grid Security and Resilience (9 papers), Lung Cancer Treatments and Mutations (5 papers) and Metabolomics and Mass Spectrometry Studies (4 papers). Hua Lin collaborates with scholars based in China, United States and Spain. Hua Lin's co-authors include James S. Thorp, Sandeep K. Shukla, Lamine Mili, Christopher H. Becker, M. Anderle, Sushmita Roy, Thomas A. Shaler, Weixun Wang, Scott M. Norton and Haihong Zhou and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Bioinformatics.

In The Last Decade

Hua Lin

40 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Quantification of Proteins and Metabolites by Mass Spectrometry without Isotopic Labeling or Spiked Standards

2003 505 citations Weixun Wang, Hua Lin et al. profile →

Peers

Countries citing papers authored by Hua Lin

Since Specialization

Citations

This map shows the geographic impact of Hua Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hua Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hua Lin more than expected).

Fields of papers citing papers by Hua Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hua Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hua Lin. The network helps show where Hua Lin may publish in the future.

Co-authorship network of co-authors of Hua Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Hua Lin. A scholar is included among the top collaborators of Hua Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hua Lin. Hua Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prognostic significance of lymphovascular invasion in patients with pT1b esophageal squamous cell carcinoma 2023 ·BMC Cancer ·(unknown), Hua Lin, (unknown), Yong Liu, (unknown), (unknown), Bingzhi Wang, Liyan Xue	4
2	Tuftelin 1 (TUFT1) Promotes the Proliferation and Migration of Renal Cell Carcinoma via PI3K/AKT Signaling Pathway 2021 ·Pathology & Oncology Research ·Hua Lin, Weifeng Zeng, (unknown), (unknown), (unknown)	14
3	Particle radiation-induced dysregulation of protein homeostasis in primary human and mouse neuronal cells 2020 ·Life Sciences in Space Research ·(unknown), Hua Lin, James Bakke, Sophia Chen, (unknown), Polly Y. Chang	4
4	Comprehensive Profiling of Gene Copy Number Alterations Predicts Patient Prognosis in Resected Stages I–III Lung Adenocarcinoma 2019 ·Frontiers in Oncology ·Xiaohong Han, (unknown), Sheng Yang, Junling Li, Jianping Xu, Xuezhi Hao, Xingsheng Hu, Puyuan Xing, Yutao Liu, Lin Lin, Lin Gui, Yan Qin, Jianliang Yang, Peng Liu, Xingyuan Wang, Wumin Dai, Dongmei Lin, Hua Lin, Yuankai Shi	23
5	[Effect of Smoking on Lung Cancer Histology and Its Epidemiology in Chinese Male]. 2017 ·SHILAP Revista de lepidopterología ·(unknown), Jibin Li, Hua Lin, (unknown), Ping Zhao	6
6	Contactin-1: a promising progression biomarker and therapeutic target of carcinoma 2017 ·Minerva Medica ·Ruijie Zhang, Lihua Xie, Chun Liu, (unknown), Hua Lin, (unknown), (unknown), Fuyun Ji, Shenghua Sun	4
7	Nimbolide suppresses non-small cell lung cancer cell invasion and migration via manipulation of DUSP4 expression and ERK1/2 signaling 2017 ·Biomedicine & Pharmacotherapy ·Hua Lin, (unknown), Lihua Xie, Chun Liu, Shenghua Sun	25
8	CNTN-1 Enhances Chemoresistance in Human Lung Adenocarcinoma Through Induction of Epithelial-Mesenchymal Transition by Targeting the PI3K/Akt Pathway 2017 ·Cellular Physiology and Biochemistry ·Ruijie Zhang, Shenghua Sun, Fuyun Ji, Chun Liu, Hua Lin, Lihua Xie, (unknown), (unknown), Yan Zhou, Jianping Xu, Pei Li	28
9	Novel Human Radiation Exposure Biomarker Panel Applicable for Population Triage 2014 ·International Journal of Radiation OncologyBiologyPhysics ·Jose G. Bazan, Polly Y. Chang, (unknown), Annalisa D’Andrea, Thomas A. Shaler, Hua Lin, Shirley Lee, Travis Harrison, (unknown), (unknown), Susan J. Knox, David E. Cooper	11
10	Co-simulating power systems and communication network for accurate modeling and simulation of PMU based wide area measurement systems using a global event scheduling technique 2013 ·(unknown), Hua Lin, Sandeep K. Shukla, James S. Thorp, Lamine Mili	11
11	Immunohistochemistry reliably detects ALK rearrangements in patients with advanced non-small-cell lung cancer 2013 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·(unknown), (unknown), Li Ma, (unknown), (unknown), (unknown), Lin Wang, Peng Liu, Zheng Yuan, Dan Li, Hua Lin, Yan Sun, (unknown)	30
12	Cyber security impacts on all-PMU state estimator - a case study on co-simulation platform GECO 2012 ·Hua Lin, Yi Deng, Sandeep K. Shukla, James S. Thorp, Lamine Mili	39
13	Genetic analysis of IREB2, FAM13A and XRCC5 variants in Chinese Han patients with chronic obstructive pulmonary disease 2011 ·Biochemical and Biophysical Research Communications ·Yi Guo, Hua Lin, Kai Gao, Hongbo Xu, Xiong Deng, Qiang Zhang, Ziqiang Luo, Shenghua Sun, Hao Deng	22
14	Power system and communication network co-simulation for smart grid applications 2011 ·Hua Lin, (unknown), Sandeep K. Shukla, James S. Thorp, Lamine Mili	135
15	AD-HOC vs. SUPERVISORY WIDE AREA BACKUP RELAY PROTECTION VALIDATED ON POWER/NETWORK CO-SIMULATION PLATFORM 2011 ·Hua Lin, (unknown), Sandeep K. Shukla, James S. Thorp, Lamine Mili	5
16	Agent Based Supervision of Zone 3 Relays to Prevent Hidden Failure Based Tripping 2010 ·(unknown), Hua Lin, (unknown), Sandeep K. Shukla, James S. Thorp	16
17	[The influence of indomethacin on TNFα and skeletal muscle protein catabolism in chronic obstructive pulmonary disease rat model]. 2010 ·PubMed ·Hua Lin, (unknown), Jian Gao, Chunying Liu, (unknown)	2
18	Identification of short-term pharmacodynamic effects of interferon-beta-1a in multiple sclerosis subjects with broad- based phenotypic profiling 2007 ·Journal of Neuroimmunology ·Aaron B. Kantor, Jun Deng, Emmanuelle Waubant, Hua Lin, Christopher H. Becker, (unknown), Andrea Perrone, Donald Bennett, Susan Goelz	22
19	[Association of MMP1 -1607(1G>2G)single nucleotide polymorphism with susceptibility to lung cancer in Northwestern Chinese population of Han nationality]. 2006 ·PubMed ·Weiqiang Zhang, Hua Lin, (unknown), Yunjie Wang, (unknown)	16
20	Biomarker discovery by comprehensive phenotyping for autoimmune diseases 2004 ·Clinical Immunology ·Aaron B. Kantor, Weixun Wang, Hua Lin, (unknown), M. Anderle, Andrea Perrone, Christopher H. Becker	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact